Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Proof of Concept for Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL) and CXCL12+ Peripheral T-Cell Lymphoma (PTCL): Preliminary Results from an Open-Label, Phase 2 Study

Blood (2019) 134 (Supplement_1): 468.

https://doi.org/10.1182/blood-2019-128513

Published: 2019

Journal Articles

Phase III Clinical Trial of Elizaria® and Soliris® in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria: Results of Comparative Analysis of Efficacy, Safety, and Pharmacological Data

Aleksandr Kulagin, Vadim Ptushkin, MD PhD Professor, Elena Lukina, MD PhD Professor, Elena Gapchenko, MD, Oksana Markova, MD MSc, Eugene Zuev, MD, Dmitry Kudlay, MD PhD Professor

Blood (2019) 134 (Supplement_1): 3748.

https://doi.org/10.1182/blood-2019-125693

Published: 2019

Journal Articles

Non-Interventional Retrospective Multicenter Study Evaluating Real Word Idelalisib Use in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma Patients Enrolled in the French Early Access Program

Loic Ysebaert, MD PhD, Pierre Feugier, Gilles Andre Salles, MD PhD, Eric Durot, MD, Alexis Talbot, MD, Choquet Sylvain, MD, Denise Glorian Kergaravat, Alastair Simpson, Heribert Ramroth, Tarek Abdelhadi, Corinne Haioun, MD, Xavier Troussard, MD

Blood (2018) 132 (Supplement 1): 5924.

https://doi.org/10.1182/blood-2018-99-110766

Published: 2018

Journal Articles

Clinical Features and Treatment Approaches in Patients with Rosai-Dorfman Disease: The Mayo Clinic Experience

Gaurav Goyal, MBBS, Aishwarya Ravindran, MBBS, Mrinal M. Patnaik, MDMBBS, Grzegorz S Nowakowski, MD, Gita Thanarajasingam, MD, Thomas M Habermann, MD, Taimur Sher, MD, Karen L Rech, MD, David J Inwards, MD, Patrick B Johnston, MD PhD, Robert Vassallo, MD, Sameer A. Parikh, MD, Ronald S. Go, MD

Blood (2017) 130 (Supplement 1): 3573.

https://doi.org/10.1182/blood.V130.Suppl_1.3573.3573

Published: 2017

Journal Articles

A Randomized, Double-Blind, Phase III Study Comparing Proposed Biosimilar Rituximab (RTXM83) Versus Reference Rituximab, Both in Combination with CHOP, in the First Line Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Myrna Candelaria, MDPharmD, Derlis Emilio Gonzalez, MD, Surender Kumar Beniwal, MD DM, Lokanatha Dasappa, MD, Daniel Oscar Bar, MD, Marcia Torresan Delamain, Ashis Mukhopadhyay, MD, David Hugo Flores, MD, Dinesh Bhurani, MD DM, FRCPA, Venkatraman Radhakrishnan, MD DM, Alejandro Salvatierra, MD, Ruben Dario Kowalyszyn, MD, Oleg Lipatov, MD, Moosa Patel, MD, Sergio Schusterschitz, MD, Elena Volodicheva, MD, Luis Antonio Perez, MD

Blood (2017) 130 (Supplement 1): 1556.

https://doi.org/10.1182/blood.V130.Suppl_1.1556.1556

Published: 2017

Journal Articles

Real-World Occurrence of Symptoms and Toxicities and Associated Cost Implications in Acute Myeloid Leukemia (AML) Treatment Episodes: A Retrospective Database Analysis in the US

Bhavik J Pandya, PharmD, Bruno C Medeiros, MD, Chi-Chang Chen, PhD, Samuel Wilson, PhD, Eric S. Groves, MD PhD, Laura Elise Horvath, MD, Rolin L. Wade, RpH, MS

Blood (2017) 130 (Supplement 1): 2118.

https://doi.org/10.1182/blood.V130.Suppl_1.2118.2118

Published: 2017

Journal Articles

Sucrosomial Iron Absorption Involve M Cells Interaction

Elisa Brilli, PhD, Pawel Lipinski, Ramon Barnadas, Mercedes Camacho, Angela Fabiano, Giulio Giordano, Francesco Equitani, MD, Germano Tarantino

Blood (2017) 130 (Supplement 1): 2217.

https://doi.org/10.1182/blood.V130.Suppl_1.2217.2217

Published: 2017

Journal Articles

The Proto-Oncogene Mer Is a Novel Therapeutic Target in Mantle Cell Lymphoma

Cunzhen Shi, Xiaogan Wang, MD, Ning Ding, MD, Lingyan Ping, Yuqin Song, MD, Jun Zhu, BS

Blood (2017) 130 (Supplement 1): 5138.

https://doi.org/10.1182/blood.V130.Suppl_1.5138.5138

Published: 2017

Journal Articles

Myeloid Sarcoma: The Mayo Clinic Experience of Ninety Six Case Series

Jennifer Yui, MD, Mythri Mudireddy, MBBS, Mrinal M Patnaik, MBBS, Naseema Gangat, MBBS, Aref Al-Kali, MD, Michelle Elliott, MD, William J. Hogan, MBChB, C. Christopher Hook, MD, Alexandra P Wolanskyj, MD, Mark R. Litzow, MD, Matthew T Howard, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh D. Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Kebede H. Begna, MD

Blood (2016) 128 (22): 2798.

https://doi.org/10.1182/blood.V128.22.2798.2798

Published: 2016

Journal Articles

Natural History of Non-Infectious, Ibrutinib-Attributable Adverse Events Leading to Alternative BTK Inhibitor Use in CLL

Polina Shindiapina, MD PhD, Soun Khountham, Kerry A. Rogers, MD, Jeffrey Jones, MD MPH, Leslie Andritsos, MD, Kami J. Maddocks, MD, Joseph M. Flynn, DO, MPH, Jennifer A. Woyach, MD, John C. Byrd, MD, Farrukh T. Awan

Blood (2016) 128 (22): 4385.

https://doi.org/10.1182/blood.V128.22.4385.4385

Published: 2016

Journal Articles

Dynamical Modeling of Clonal Evolution in Paired Primary and Relapsed Follicular Lymphoma Predicts a Link Between Cell Migration and Evolutionary Heterogeneity

Matthias Horn, PhD, Markus Kreuz, PhD, Ralf Küppers, PhD, Markus Loeffler, MD PhD

Blood (2016) 128 (22): 2929.

https://doi.org/10.1182/blood.V128.22.2929.2929

Published: 2016

Journal Articles

Clinical Impact of Different Levels of VEGF-C on Leukemic Blasts in the Bone Marrow and Peripheral Blood of Acute Myeloid Leukemia

Sung-Eun Lee, Ji Yoon Lee, A-Reum Han, Woo-Sung Min, Heeje Kim

Blood (2016) 128 (22): 1670.

https://doi.org/10.1182/blood.V128.22.1670.1670

Published: 2016

Journal Articles

Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study

Baba Inusa, Raffaella Colombatti, MD PhD, David C Rees, MA, FRCP, Matthew M Heeney, MD, Carolyn C Hoppe, MD, Bernhards Ogutu, MD PhD, Hoda M Hassab, MD, Chunmei Zhou, MS, Suqin Yao, PhD, Patricia B Brown, BSN, RN, Lori E Heath, MS, Joseph A. Jakubowski, PhD, Miguel R Abboud, MD

Blood (2016) 128 (22): 3653.

https://doi.org/10.1182/blood.V128.22.3653.3653

Published: 2016

Journal Articles

Comparison of the Safety Profile of Sickle Cell Disease Patients Treated with Hydroxycarbamide in Off-Label Versus in-Label Prescriptions in the Escort-HU Non Interventional, Prospective, Observational Open-Label Cohort Study

Ersi Voskaridou, MD, Stephan Lobitz, MD, Uwe Kordes, MD MRCP, Regine Grosse, MD, Valentine Brousse, MD, Malika Benkerrou, MD, Mariane De Montalembert, MD PhD, Jean-Antoine Ribeil, MD PhD, Frederic Galacteros, MD PhD

Blood (2016) 128 (22): 2497.

https://doi.org/10.1182/blood.V128.22.2497.2497

Published: 2016

Journal Articles

Prophylactic Biosimilar Filgrastim Treatment during Cytotoxic Chemotherapy in Patients with Malignant Diseases: The Venice Observational Study

Burkhard Otremba, MD, Wolfhard Erdlenbruch, MD

Blood (2015) 126 (23): 2215.

https://doi.org/10.1182/blood.V126.23.2215.2215

Published: 2015

Journal Articles

The Tumor Microenvironment in Mantle Cell Lymphoma (MCL): Novel Targets to Overcome Chemo-Resistance in MCL

Lan V Pham, PhD, Archito T. Tamayo, MS, Elizabeth Pogue, Gary Lu, MD, Pramoda Challagundla, Jeffrey L. Jorgensen, MD PhD, Liang Zhang, MD PhD, Michael Wang, MD, Richard J. Ford, MD PhD

Blood (2014) 124 (21): 494.

https://doi.org/10.1182/blood.V124.21.494.494

Published: 2014

Journal Articles

An Interactive 3D Lymphoma's Stage Calculator Assistant: A New Tool to Help Hematologists in Routine Practice

Mohamed Touati, MD, Jeremy Assenat, Jacques Monteil, MD, Philippe De Souza, MD, Magdalena Munyamahoro, Sandra Juge, Pierre-Marie Preux, MD, Arnaud Jaccard, MD, Dominique Bordessoule, MD

Blood (2014) 124 (21): 1323.

https://doi.org/10.1182/blood.V124.21.1323.1323

Published: 2014

Journal Articles

Implementation of a European Cohort to Follow Sickle Cell Children and Adults Treated with Hydroxycarbamide

Mariane De Montalembert, MD, Frédéric Galacteros, Jean Antoine Ribeil, MD PhD, Uwe Kordes, MD MRCP, Jean Benoit Arlet, MD PhD, M Dimopoulou, MD, V Komninaka, MD, Pablo Bartolucci, MD PhD, Anoosha Habibi, Valentine Brousse, MD, Justine Gellen, MD, Stephen Lobitz, MD, Ersi Voskaridou, MD

Blood (2014) 124 (21): 564.

https://doi.org/10.1182/blood.V124.21.564.564

Published: 2014

Journal Articles

Lymphomania

Robert K. Andrews, Elizabeth E. Gardiner

Blood (2014) 123 (20): 3057–3058.

https://doi.org/10.1182/blood-2014-02-557371

Published: 2014

Journal Articles

Impact Of Low-Grade Adverse Events (AEs) On Health-Related Quality Of Life (HRQoL) In Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia In Chronic Phase (Ph+ CML-CP) From The Enestnd Trial: 48-Month Follow-Up

Lei Chen, MD, PhD, Annie Guerin, MSc, Maryna Marynchenko, MBA, Raluca Ionescu-Ittu, PhD, Robert Hiscock, MSc, Roy Nitulescu, MA, Chopra Pooja, MSc, Ling-I Hsu, MPH, Christopher Keir, MD, Eric Qiong Wu, PhD

Blood (2013) 122 (21): 4038.

https://doi.org/10.1182/blood.V122.21.4038.4038

Published: 2013

NARROW

Proof of Concept for Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL) and CXCL12+ Peripheral T-Cell Lymphoma (PTCL): Preliminary Results from an Open-Label, Phase 2 Study

Phase III Clinical Trial of Elizaria® and Soliris® in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria: Results of Comparative Analysis of Efficacy, Safety, and Pharmacological Data

Non-Interventional Retrospective Multicenter Study Evaluating Real Word Idelalisib Use in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma Patients Enrolled in the French Early Access Program

Clinical Features and Treatment Approaches in Patients with Rosai-Dorfman Disease: The Mayo Clinic Experience

A Randomized, Double-Blind, Phase III Study Comparing Proposed Biosimilar Rituximab (RTXM83) Versus Reference Rituximab, Both in Combination with CHOP, in the First Line Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Real-World Occurrence of Symptoms and Toxicities and Associated Cost Implications in Acute Myeloid Leukemia (AML) Treatment Episodes: A Retrospective Database Analysis in the US

Sucrosomial Iron Absorption Involve M Cells Interaction

The Proto-Oncogene Mer Is a Novel Therapeutic Target in Mantle Cell Lymphoma

Myeloid Sarcoma: The Mayo Clinic Experience of Ninety Six Case Series

Natural History of Non-Infectious, Ibrutinib-Attributable Adverse Events Leading to Alternative BTK Inhibitor Use in CLL

Dynamical Modeling of Clonal Evolution in Paired Primary and Relapsed Follicular Lymphoma Predicts a Link Between Cell Migration and Evolutionary Heterogeneity

Clinical Impact of Different Levels of VEGF-C on Leukemic Blasts in the Bone Marrow and Peripheral Blood of Acute Myeloid Leukemia

Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study

Comparison of the Safety Profile of Sickle Cell Disease Patients Treated with Hydroxycarbamide in Off-Label Versus in-Label Prescriptions in the Escort-HU Non Interventional, Prospective, Observational Open-Label Cohort Study

Prophylactic Biosimilar Filgrastim Treatment during Cytotoxic Chemotherapy in Patients with Malignant Diseases: The Venice Observational Study

The Tumor Microenvironment in Mantle Cell Lymphoma (MCL): Novel Targets to Overcome Chemo-Resistance in MCL

An Interactive 3D Lymphoma's Stage Calculator Assistant: A New Tool to Help Hematologists in Routine Practice

Implementation of a European Cohort to Follow Sickle Cell Children and Adults Treated with Hydroxycarbamide

Lymphomania

Impact Of Low-Grade Adverse Events (AEs) On Health-Related Quality Of Life (HRQoL) In Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia In Chronic Phase (Ph+ CML-CP) From The Enestnd Trial: 48-Month Follow-Up

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only